WallStreetZenWallStreetZen

NASDAQ: APRE
Aprea Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for APRE

Based on 2 analysts offering 12 month price targets for Aprea Therapeutics Inc.
Min Forecast
$16.00+343.21%
Avg Forecast
$18.00+398.61%
Max Forecast
$20.00+454.02%

Should I buy or sell APRE stock?

Based on 2 analysts offering ratings for Aprea Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their APRE stock forecasts and price targets.

APRE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 10%
91
BuyReiterates$20.00+454.02%2023-05-16
Maxim Group
Bottom 3%
3
Strong BuyInitiates Coverage On$16.00+343.21%2023-03-10

1 of 1

Forecast return on equity

Is APRE forecast to generate an efficient return?
Company
N/A
Industry
0.1%
Market
71.96%

Forecast return on assets

Is APRE forecast to generate an efficient return on assets?
Company
N/A
Industry
0.12%

APRE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
APRE$3.61$18.00+398.61%Strong Buy
UPC$0.62N/AN/A
AEZS$2.75$28.00+918.55%Buy
FREQ$0.37$5.50+1,386.49%Strong Buy
ATHE$2.85N/AN/A

Aprea Therapeutics Stock Forecast FAQ

Is Aprea Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: APRE) stock is to Strong Buy APRE stock.

Out of 2 analysts, 1 (50%) are recommending APRE as a Strong Buy, 1 (50%) are recommending APRE as a Buy, 0 (0%) are recommending APRE as a Hold, 0 (0%) are recommending APRE as a Sell, and 0 (0%) are recommending APRE as a Strong Sell.

If you're new to stock investing, here's how to buy Aprea Therapeutics stock.

What is APRE's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: APRE) forecast ROE is N/A, which is considered weak.

What is APRE's Price Target?

According to 2 Wall Street analysts that have issued a 1 year APRE price target, the average APRE price target is $18.00, with the highest APRE stock price forecast at $20.00 and the lowest APRE stock price forecast at $16.00.

On average, Wall Street analysts predict that Aprea Therapeutics's share price could reach $18.00 by May 16, 2024. The average Aprea Therapeutics stock price prediction forecasts a potential upside of 398.61% from the current APRE share price of $3.61.

What is APRE's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: APRE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.